<DOC>
	<DOC>NCT00867399</DOC>
	<brief_summary>The objectives of this study are to assess the safety, tolerability and pharmacokinetics of ABT-126 in elderly subjects.</brief_summary>
	<brief_title>A Safety and Tolerability Study of ABT-126 in Elderly</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Healthy male or female subjects 65 years or greater. Has a MMSE score of 27 or higher. History of dementia including by not limited to Alzheimer's disease, Parkinson's disease and multinfarct dementia. History of any significant neurological disease. Has an estimated creatinine clearance &lt; 30 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>